Your Advocates Ltd’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-12
Closed -$1.14K 210
2024
Q3
$1.14K Hold
12
﹤0.01% 192
2024
Q2
$1.15K Hold
12
﹤0.01% 194
2024
Q1
$1.58K Hold
12
﹤0.01% 181
2023
Q4
$1.73K Hold
12
﹤0.01% 178
2023
Q3
$2.04K Hold
12
﹤0.01% 196
2023
Q2
$2.68K Hold
12
﹤0.01% 200
2023
Q1
$2.65K Hold
12
﹤0.01% 163
2022
Q4
$2.6K Buy
+12
New +$3.2K ﹤0.01% 147
2022
Q2
Sell
-12
Closed -$3K 205
2022
Q1
$3K Hold
12
﹤0.01% 149
2021
Q4
$3K Hold
12
﹤0.01% 138
2021
Q3
$3K Hold
12
﹤0.01% 141
2021
Q2
$2K Hold
12
﹤0.01% 121
2021
Q1
$2K Hold
12
﹤0.01% 119
2020
Q4
$2K Buy
+12
New +$1.43K ﹤0.01% 122
2020
Q3
Sell
-12
Closed -$1K 138
2020
Q2
$1K Hold
12
﹤0.01% 125
2020
Q1
$1K Buy
+12
New +$920 ﹤0.01% 112

Other funds holding ALB

Your Advocates Ltd's ALB Position: Q4 2024 in Review

Your Advocates Ltd sold out of Albemarle (ALB) in Q4 2024, closing a stake of 12 shares — an estimated $1.14K sold.

Your Advocates Ltd first reported a position in ALB in Q1 2020 and held it in 16 quarters. The position peaked at $3K in Q1 2022. 805 funds tracked by Wall St. Rank hold ALB as of Q4 2024.

  • Your Advocates Ltd reported no remaining Albemarle position as of Q4 2024 after selling out during the quarter.
  • Your Advocates Ltd sold 12 Albemarle shares in Q4 2024, an estimated $1.14K.
  • Your Advocates Ltd first reported a position in Albemarle in Q1 2020 and held it in 16 quarters.
  • Your Advocates Ltd's Albemarle position peaked at $3K in Q1 2022.
  • 805 funds tracked by Wall St. Rank held Albemarle as of Q4 2024.

Based on Your Advocates Ltd's 13F filing for Q4 2024, filed 4 Feb 2025.